Evidence suggests that insulin is under-prescribed in older people. Some reasons for this include physician's concerns about potential side-effects or patients' resistance to insulin. In general, however, little is known about how GPs make decisions related to insulin prescribing in older people.
INTRODUCTION
Current prevalence figures estimate that 16% of people aged 65 years and over have diabetes. 1, 2 In 1995, the number of people aged 65 years and over with type 2 diabetes in the developed world was 28 million -this is expected to double by 2025. 3 In the UK, it is estimated that between 10% and 25% of older people have diabetes. 4 As healthcare provision shifts from secondary to primary care, type 2 diabetes management continues to be a growing and expected part of the GP's role. In an increasingly ageing population of people with type 2 diabetes, tighter control, including greater use of insulin and combination therapies, may be important in ensuring better outcomes and fewer complications, and may also be helpful in the day-to-day management of diabetes. [5] [6] [7] [8] [9] There is some literature to suggest that in older people insulin may be under-prescribed. 10 In 1999, only 11% of older people with diabetes were prescribed insulin (compared with approximately 40% in either: engaged diet change or taking oral hypoglycaemics). 10 Some specialists believe that GPs fuel patient resistance to insulin, 11 and postpone its use despite high patient plasma-glucose levels, 12 yet little information is known about the GP perspective. This study fills an important gap by exploring the process and rationale for prescribing decisions of GPs regarding insulin when treating older adults with type 2 diabetes.
METHOD
Qualitative research methods were used. Sampling was purposive and an attempt was made to find physicians that varied in age, type of practice (academic versus non-academic), and sex. In order to focus the search for GPs, potential participants were randomly selected from a list of actively practising GPs within a 1-hour driving radius of a large suburban city in Ontario, Canada (Canadian Medical Directory of Doctors). 13 GPs were randomly sampled from this list, given the large number of physicians in the geographic area of interest. Letters of invitation that outlined study requirements were mailed to eligible doctors; those that expressed an interest in participating were contacted and consented by a research assistant.
An experienced, trained interviewer conducted the in-person interviews using a semi-structured interview guide that focused on eliciting information related to the process used and factors considered when prescribing insulin. The interview guide was modified as interviews proceeded to reflect emerging themes that required further exploration. 14, 15 Participant demographic information was also collected. Interviewing continued until no new ideas emerged and theoretical explanations of emerging phenomena were evident. 16 Interviews were recorded and transcribed verbatim.
Data were analysed using a grounded theory approach as the study aim was to understand the process of decision making related to insulin use in older people and the factors that influence this process. 15 Two investigators independently read all transcripts and discussed the findings with the research team, ensuring that emerging themes received adequate opportunity for discussion to allow the developing theory to become saturated. 17 This involved repeated reading of all transcripts during the coding process to ensure that there was both depth and breadth within each theme, and that disconfirming evidence had also been accounted for in the analysis. Investigators validated themes by referring back to the original transcripts. Data collection stopped when saturation was reached as denoted by a repetition in information being heard in the interviews. 18 Qualitative software (QSR NUD*IST, NVivo) was used to assist with data organisation.
RESULTS
Twenty-one GPs were interviewed for approximately 50 minutes each. Sixteen doctors were male. The median age of participants was 54 years (range 37-74 years) and the median length of time since graduation was 27 years (range 8-46 years). Nine GPs described themselves as being academic practitioners.
Seven main factors influenced insulin prescribing, and each is described in more detail below.
GPs' beliefs about older people
GPs believed their older patients had many physical concerns, such as eyesight problems and compromise with manual dexterity, that could cause difficulties in insulin administration and selfmonitoring. They were also concerned that possible cognitive impairment could affect patients' ability to recall taking medication. They believed older people might react differently to medications in general, compared with older patients, and felt they had a higher risk of developing a hypoglycaemic episode after insulin therapy: 
How this fits in
Insulin therapy is under-prescribed in older people, and some known factors that influence prescribing are GPs' concerns about patient resistance to insulin and potential side-effects. This study has helped to identify that both patient and physician factors have an impact on insulin prescribing, with GPs' intended and actual prescribing varying depending on their assessment of the patients' situation. Under-prescribing of insulin in older people could be improved by more GP education, better specialist-GP communication, and the use of more allied health professionals to provide support networks for patients and GPs. more compliant with new regimens than younger patients. Many GPs described how the challenges of initiating insulin therapy became easier as patients were encouraged by symptom improvement, and as medication-related issues were discussed to improve knowledge.
GPs' beliefs about diabetes and its management
General beliefs related to diabetes were discussed that reflected experience with managing chronic illnesses. Many GPs felt providing diabetes care caused a high clinical burden and increased the need for greater vigilance. For example, more tests and adherence to strict standards of monitoring added to already time-pressed consultations:
'The huge thing, which is raising its head already and will in the future, is the enormous burden of people with diabetes. The ever-increasing demand to reach tighter and tighter guidelines, and the limited resources available to help us do that. So in an ideal world we could do more and do it better if we were more available. So in an ideal world you'd be on the phone with someone very regularly, as often as once every 2 or 3 days to do adjustments and get it right. It's not, it's barely realistic now and it will become less and less realistic next year and the year after and the year after.' (GP, 8)
GPs described diabetes as a disease that required self-management and input or ownership from patients. Empowering patients could be challenging, although very necessary in order to foster testing of blood sugars and improve understanding of why testing is needed. Patient self-management, though key, was difficult to foster: 
Gauging the intensiveness of therapy required
Views varied among participants regarding how aggressively to treat older patients with diabetes. Most doctors felt less stringent control in this age group was acceptable. Many expressed frustration that there seemed to be no definitive evidence upon which to base their actions; therefore, GPs used their own experience and beliefs to inform their actions: Some GPs expressed the view that age alone should not necessarily be a sufficient indicator of physiological characteristics. They felt that there was a distinction between 'young-old' and 'old-old', almost drawing a line between the 65-year to late-70-year-old age group, who appear fitter and healthier, and the over-80-year-old age group who seem to be more frail. However, GPs also recognised that some older people did not fit into these stereotypes about age, and preferred to personalise the care that they offered: In their 'personalisation of therapy', GPs were aware they were making an assessment of a patient's quality of life and that this would influence their prescribing behaviour. They sought affirmation of their assessments by having ongoing discussions with their patients and checking whether the patients' assessment of their quality of life was similar: 
Need for preparation for insulin therapy
Participants noted a patient's reaction towards needles as a significant barrier to prescribing insulin. The very words 'needle' or 'injection' carried complex connotations and, sometimes, the suggestion of starting insulin could signify a message of failure in other therapies to the patient, that is, that 'drastic' measures were now needed. GPs were cognisant of the psychological hurdles patients would need to surmount in order to feel more comfortable with commencing insulin treatment, and the need for multiple discussions to lessen the fears their patients had. In this way, GPs sought to 'lay the groundwork' for the experience of going onto insulin to ensure future success: Once the decision to start insulin has been made, preparation for therapy seems to be a central factor that leads patients' practitioners to switch from the decision to prescribe to the decision not to prescribe, or vice versa. This preparation for therapy could be done by a variety of people (practice nurse, diabetes educator, or GP), over several visits and in different settings (GP surgery, hospital, or local diabetes education centres).
' ... I think it's helpful if it's introduced as just a one-time thing at night to start, and then it's a gradual stepwise approach, and you don't just

Support with insulin administration for patients from informal or formal healthcare provider
All participants indicated that patient support (whether from family or health professionals) was important for them and their patients in the decision to commence insulin therapy. The support and presence of family members was essential for an older person to take insulin, whether in a role of overseeing everything totally, or a supportive adjunct to monitor progress independently and to check the process: 19) In some cases, not wanting to put a burden on the family was a deterrent for starting insulin. In situations where the older patient received constant assistance from a caregiver/nurse, it was easier to recommend insulin, as the GP felt someone reliable would be administering the medications. However, GPs also recognised the burdens on the caregivers too: GPs also relied on specialists or clinics to reinforce the need for insulin, and on nurses to assist with teaching and monitoring. The assistance provided helped the GP overcome the initial barriers to starting insulin, and provided valuable time and input where he or she was burdened due to other practice pressures:
'Oh I'm lucky, I'm very lucky because I have a diabetic nurse who comes in on Saturdays and brings in all the pens and things and sits them down, and explains it to patients, gives them a sample and says, "this is what you do".' (GP, 19)
Frustration with management complexity
Some participants expressed a frustration towards the multiplicity of factors related to the prescribing, monitoring, and use of insulin, the complexity of the treatment regimens, and the work implications of needing to start a patient on insulin. They felt many patients did not adequately understand the longterm ramifications of diabetes and how important insulin therapy could potentially be. For some GPs, these feelings were 'countered' by access to a good support system: 'Well frustration is one of them. You know you're trying to impress upon them [patients] this is important to their health, and for one reason or another you know, they're not getting it.' (GP, 11)
The addition of another layer of treatment such as insulin, which would make treatment even more complex, was challenging, and added further difficulties around administration, monitoring, dosing, and possibilities of mistakes and sideeffects, which were hard to face knowingly. This sentiment seems to be able to influence the decision to actually prescribe insulin or not, despite the assessment of a patient's need for it.
GPs' experience with insulin administration
Within this group, most GPs had little experience of treating older patients with insulin. This lack of experience made some apprehensive about initiating it. Many used a referral to a local diabetes clinic to support their decision to commence insulin: Conversely, GPs also described situations where their own experience or knowledge of particular nursing homes or less-than-ideal care situations, hindered them from considering insulin treatment as a viable option. Thus, the presence of support is a factor that can facilitate GPs in starting insulin, helping them to action this decision.
Variability in doctors' approach
An overall observation was also made that there was a mismatch between what GPs considered ideal practice and what they themselves were able to offer in their individual settings. Some reasons for this mismatch between intent and behaviour included the GP's assessment that the quality of life of the individual patient needed to be considered; a sense that a more cautious approach was needed in real life; and a belief that less-tight control is acceptable when treating real-life older patients in reality. This highlights the likely unconscious beliefs that influence how treatment prescribing occurs in practice: 
DISCUSSION
Summary of main findings
This study demonstrates a wide range of factors that influence GPs' prescribing of insulin for older people. Personal beliefs and appraisals of the older population, diabetes, and the intensiveness of insulin therapy influence GPs' decision making. Once the initial decision has been made to commence insulin, GPs will be further influenced in their decision to proceed by the level of available support from the patient's family or from professionals. GPs identified the importance of thoroughly preparing their patients for the decision to start insulin before initiating insulin therapy in this age group.
Strengths and limitations of the study
The study utilised many steps to ensure rigour in its design. The cleaning of transcripts for accuracy, involving multiple investigators in the coding and analysis, and refining the interview guide to capture emerging themes helped to facilitate the saturation of themes. Despite these strengths, however, it is acknowledged that this sample of 21 GPs did not allow for in-depth comparison of different types of GPs (for example, rural versus urban, solo versus group practice). In addition, although GPs were screened prior to the interview to make certain that they did have seniors with diabetes in their practice, very few had actually initiated the use of insulin; it is recognised that this may not be reflective of practices at large. However, this was reflective of the sample that was interviewed, as purposive samples were used that included GPs with older patients, and this indicates the state of experience in the study area.
Comparison with existing literature
Previous research has also found that doctors' belief systems affect how they prescribe. 19 However, what specialists may have previously felt to be a dangerous 'postponement' 19 could, in fact, be part of a necessary and lengthy preparation process with the patient. GPs were careful to discuss issues that may affect quality of life (for example, patient fear), and also revisited these issues in subsequent consultations.
The finding that GPs may not have a standard approach for all older patients with diabetes may also be explained by their ability to gauge a situation based on intimate knowledge of their patients' background and personality. This reflects the process of individualising therapy, rather than a consistent 'disconnect' between stated and actual behaviour. For example, GPs develop a threshold for the maximum number of medications they are willing to prescribe to a patient, but this number will vary among their patients.
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Implications for future research and clinical practice
This study offers useful insights regarding factors that influence insulin prescribing in older people in the primary care setting. In a scenario of ever-increasing numbers of older people with type 2 diabetes, GP prescribing of insulin would benefit from further support and intervention. Future research that purposefully seeks out GPs with experience of prescribing and monitoring insulin, as well as those that have deferred this route, would contribute to the literature.
Next steps could include GP-targeted education modules to clarify the evidence for use of insulin in older people, and focused on better communication between specialists and GPs. A trial testing different modes of education could help to inform how best to improve GP confidence in insulin prescribing. If left unaddressed, the under-prescribing of insulin due to the subconscious beliefs of GPs could increase the numbers of older people with poorly controlled type 2 diabetes.
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